- Cancer-type dependent expression of CK2 transcripts
Melissa M. J. Chua et al, 2017, PLoS ONE CrossRef - Synthesis and biological evaluation of novel amino-substituted derivatives of pyrido[2,3-d]pyrimidine as inhibitors of protein kinase CK2
A. N. Zinchenko et al, 2017, Biopolym. Cell CrossRef - Protein kinase CK2 modulation of pyruvate kinase M isoforms augments the Warburg effect in cancer cells
Kyung Mi Yang et al, 2018, J Cell Biochem CrossRef - Co-expression network analysis identifies a gene signature as a predictive biomarker for energy metabolism in osteosarcoma
Naiqiang Zhu et al, 2020, Cancer Cell Int CrossRef - Protein kinase CK2: a potential therapeutic target for diverse human diseases
Christian Borgo et al, 2021, Sig Transduct Target Ther CrossRef - CX-4945 and siRNA-Mediated Knockdown of CK2 Improves Cisplatin Response in HPV(+) and HPV(−) HNSCC Cell Lines
Janeen H. Trembley et al, 2021, Biomedicines CrossRef - CK2α/CSNK2A1 Induces Resistance to Doxorubicin through SIRT6-Mediated Activation of the DNA Damage Repair Pathway
Usama Khamis Hussein et al, 2021, Cells CrossRef - Simultaneous CK2/TNIK/DYRK1 inhibition by 108600 suppresses triple negative breast cancer stem cells and chemotherapy-resistant disease
Katsutoshi Sato et al, 2021, Nat Commun CrossRef - Targeting CK2 in cancer: a valuable strategy or a waste of time?
Mauro Salvi et al, 2021, Cell Death Discov. CrossRef -
4,5,7‐Trisubstituted indeno[1,2‐
b
]indole inhibits CK2 activity in tumor cells equivalent to CX‐4945 and shows strong anti‐migratory effects
Robin Birus et al, 2021, FEBS Open Bio CrossRef - Molecular targets and therapeutic strategies for triple-negative breast cancer
Yashasvi Bhat et al, 2023, Mol Biol Rep CrossRef - Scoping Pleiotropy of CK2 in Musculoskeletal Disorders for a Novel Targeting Approach
Venu Pandit et al, 2024, Kinases and Phosphatases CrossRef - CK2 Inhibitors Targeting Inside and Outside the Catalytic Box
Sophie Day-Riley et al, 2024, Kinases and Phosphatases CrossRef